AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix 
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies 
BOJ’s Himino Signals Timely Rate Hikes as Inflation Risks Rise 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger 
Pentagon Eyes 100-Year Lease on Venezuela Oil Fields 
Gold Prices Fall as Stronger Dollar, Fed Rate Outlook Weigh 
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Sweden Retail Sales Slip 0.2% in July 
Add as a preferred source on Google
A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.
